Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 11, 2023 07:00 ET | Source: Acasti Pharma, Inc.

Acasti Announces First Quarter 2024 Financial Results and Business Highlights

New leadership team singularly focused on executing GTX-104 strategyAnnounced alignment with the U.S. Food and Drug Administration (FDA) for Pivotal STRIVE-ON Phase 3 Safety Trial for GTX-104 with...
August 09, 2023 16:05 ET | Source: Acasti Pharma, Inc.

Acasti to Present GTX-104 Pharmacokinetic Comparison Data at Neurocritical Care Annual Meeting

PRINCETON, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) ("Acasti" or the "Company"), a late-stage, biopharma company advancing GTX-104 its novel formulation of...